期刊文献+
共找到16篇文章
< 1 >
每页显示 20 50 100
八段锦联合五劳七损方对强直性脊柱炎患者躯体功能及心理健康状况的影响 被引量:4
1
作者 付金钰 唐锐 +1 位作者 李晓娟 田雪梅 《西部中医药》 2016年第6期124-126,共3页
目的:观察八段锦联合五劳七损方对强直性脊柱炎(ankylosing spondylitis,AS)患者躯体功能及心理健康状况的影响。方法:将70例患者随机分为观察组、对照组各35例,2组均给予美洛昔康片治疗,观察组同时给予八段锦联合五劳七损方内服,6个月... 目的:观察八段锦联合五劳七损方对强直性脊柱炎(ankylosing spondylitis,AS)患者躯体功能及心理健康状况的影响。方法:将70例患者随机分为观察组、对照组各35例,2组均给予美洛昔康片治疗,观察组同时给予八段锦联合五劳七损方内服,6个月后观察疾病活动指数(BASDAI)、功能指数(BASFI)、疼痛评分(VAS)、晨僵时间、血沉(ESR)、C-反应蛋白(CRP)、精神症状自评量表(SCL-90)评分。结果:BASDAI、BASFI、疼痛评分、晨僵时间、ESR、CRP治疗后2组均有改善(P<0.05),观察组较对照组改善更明显(P<0.05)。SCL-90评分各因子得分2组治疗后均明显降低(P<0.05),人际关系、抑郁、焦虑评分观察组降低更明显(P<0.05)。结论:八段锦联合五劳七损方有助于改善AS患者躯体功能及心理健康状况。 展开更多
关键词 脊柱炎 强直性 八段锦 五劳七损 躯体功能 心理健康
下载PDF
五劳七损方治疗强直性脊柱炎50例临床研究 被引量:7
2
作者 苏小军 王海东 +3 位作者 田雪梅 王爱华 吴燕 李伟青 《新中医》 CAS 2013年第11期52-54,共3页
目的:观察五劳七损方治疗强直性脊柱炎的疗效与安全性。方法:对50例患者予五劳七损方治疗,治疗6月后观察治疗效果。结果:临床总有效率为96.0%;治疗后患者晨僵时间、脊柱痛评分、全身疼痛评分、疾病活动指数、关节功能指数、医生总体评... 目的:观察五劳七损方治疗强直性脊柱炎的疗效与安全性。方法:对50例患者予五劳七损方治疗,治疗6月后观察治疗效果。结果:临床总有效率为96.0%;治疗后患者晨僵时间、脊柱痛评分、全身疼痛评分、疾病活动指数、关节功能指数、医生总体评价、枕墙距、胸廓活动度、Schober征、指地距、血沉、C-反应蛋白等各项指标均有不同程度改善,与治疗前比较,差异有显著性或非常显著性意义(P<0.05,P<0.01)。所有患者未出现血、尿常规异常及肝、肾功能损害。结论:五劳七损方对强直性脊柱炎安全有效。 展开更多
关键词 强直性脊柱炎(AS) 中医疗法 五劳七损
下载PDF
小针刀配合五劳七损方治疗强直性脊柱炎髋关节病变30例 被引量:7
3
作者 王爱华 王海东 《西部中医药》 2015年第4期120-122,共3页
目的:观察小针刀配合五劳七损方治疗强直性脊柱炎髋关节病变的临床疗效。方法:将60例强直性脊柱髋关节病变患者随机分为对照组和观察组各30例,观察组给予小针刀配合五劳七损方治疗,对照组给予针刺配合五劳七损方治疗,记录治疗前及治疗... 目的:观察小针刀配合五劳七损方治疗强直性脊柱炎髋关节病变的临床疗效。方法:将60例强直性脊柱髋关节病变患者随机分为对照组和观察组各30例,观察组给予小针刀配合五劳七损方治疗,对照组给予针刺配合五劳七损方治疗,记录治疗前及治疗后15天患者髋关节的VAS评分及Harris评分,并做统计分析。结果:愈显率观察组为73.3%,对照组为60.0%,2组比较差异具有统计学意义(P<0.05)。VAS评分及Harris评分治疗后2组均明显改善(P<0.05),观察组改善更明显(P<0.05)。结论:小针刀配合五劳七损方治疗强直性脊柱炎髋关节病变疗效优于针刺配合五劳七损方治疗者。 展开更多
关键词 髋关节病变 强直性脊柱炎 小针刀疗法 五劳七损
下载PDF
五劳七损方治疗产后痹44例 被引量:2
4
作者 王爱华 《中医研究》 2013年第9期14-16,共3页
目的:观察《武威汉代医简》之五劳七损方治疗产后痹的临床疗效。方法:将85例产后痹患者采用随机数字表法随机分为治疗组44例和对照组组40例,治疗组给予五劳七损方,1 d 1剂,分2次口服;对照组给予口服益肾蠲痹丸,8 g/次,3次/d。两组均以1... 目的:观察《武威汉代医简》之五劳七损方治疗产后痹的临床疗效。方法:将85例产后痹患者采用随机数字表法随机分为治疗组44例和对照组组40例,治疗组给予五劳七损方,1 d 1剂,分2次口服;对照组给予口服益肾蠲痹丸,8 g/次,3次/d。两组均以1个月为1个疗程,连续治疗3个疗程后判定疗效。结果:治疗组临床控制17例,显效13例,有效12例,无效2例,有效率占95.46%;对照组临床控制9例,显效10例,有效12例,无效9例,有效率占77.50%。两组对比,差别有统计学意义(P<0.05)。结论:《武威汉代医简》之五劳七损方治疗产后痹,疗效确切。 展开更多
关键词 产后痹 中医药疗法 临床观察 武威汉代医简 五劳七损 治疗应用
下载PDF
五劳七损方治疗膝骨性关节炎40例 被引量:2
5
作者 王爱华 《中医临床研究》 2016年第23期103-104,共2页
目的:观察《武威汉代医简》之五劳七损方治疗膝骨性关节炎的临床疗效。方法:将80例患者随机分为两组,治疗组采用《武威汉代医简》之五劳七损方治疗膝骨性关节炎,对照组给予口服益肾蠲痹丸,比较两组的临床疗效。结果:治疗组有效率为95.0... 目的:观察《武威汉代医简》之五劳七损方治疗膝骨性关节炎的临床疗效。方法:将80例患者随机分为两组,治疗组采用《武威汉代医简》之五劳七损方治疗膝骨性关节炎,对照组给予口服益肾蠲痹丸,比较两组的临床疗效。结果:治疗组有效率为95.00%,高于对照组之78.95%,且不良反应少。结论:《武威汉代医简》之五劳七损方治疗膝骨性关节炎疗效确切。 展开更多
关键词 膝骨性关节炎 中医药疗法 《武威汉代医简》 五劳七损
下载PDF
五劳七损方治疗强直性脊柱炎42例 被引量:1
6
作者 王海东 金芳梅 《医学信息》 2012年第11期324-325,共2页
目的观察《武威江代医简》之五劳七损方治疗强直性脊柱炎的临床疗效。方法将86例患者随机分为两组,治疗组采用《武威汉代医简》之五劳七损方治疗强直性脊柱炎,对照组给予口服柳氮磺吡啶片及益肾蠲痹丸,比较两组的临床疗效。结累治疗... 目的观察《武威江代医简》之五劳七损方治疗强直性脊柱炎的临床疗效。方法将86例患者随机分为两组,治疗组采用《武威汉代医简》之五劳七损方治疗强直性脊柱炎,对照组给予口服柳氮磺吡啶片及益肾蠲痹丸,比较两组的临床疗效。结累治疗组有效率占95.24%,高于对照组之78.95%,且不良反应少。结论《武威汉代医简》之五劳七损方治疗强直性脊柱炎疗效确切。 展开更多
关键词 强直性脊柱炎 中医药疗法 武威汉代医简 五劳七损
下载PDF
五劳七损方加味治疗肝肾亏虚型腰椎间盘突出症临床疗效 被引量:10
7
作者 辛卓萍 《西部中医药》 2018年第1期89-91,共3页
目的:观察五劳七损方治疗肝肾亏虚型腰椎间盘突出症的临床疗效。方法:将肝肾亏虚型腰椎间盘突出症患者60例随机分为治疗组和对照组,每组30例,治疗组给予五劳七损方治疗,对照组给予双氯芬酸钠缓释胶囊治疗,比较治疗前及治疗15天后2组患者... 目的:观察五劳七损方治疗肝肾亏虚型腰椎间盘突出症的临床疗效。方法:将肝肾亏虚型腰椎间盘突出症患者60例随机分为治疗组和对照组,每组30例,治疗组给予五劳七损方治疗,对照组给予双氯芬酸钠缓释胶囊治疗,比较治疗前及治疗15天后2组患者JOA评分及临床疗效。结果:愈显率治疗组为73.3%,对照组为70.0%,2组比较差异无统计学意义(P>0.05);JOA评分2组治疗后均较治疗前升高,差异有统计学意义(P<0.05),治疗后2组比较差异无统计学意义(P>0.05)。不良反应率治疗组为3.3%,对照组为20.0%,2组比较差异有统计学意义(P<0.05)。结论:五劳七损方治疗肝肾亏虚型腰椎间盘突出症与双氯芬酸钠缓释胶囊疗效相当,但五劳七损方对胃肠道的不良反应低于双氯芬酸钠缓释胶囊。 展开更多
关键词 椎间盘移位 腰椎 肝肾亏虚型 五劳七损
下载PDF
七损八益考补说 被引量:1
8
作者 猪饲祥夫 《新中医》 CAS 北大核心 1990年第9期2-6,共5页
有关七损八益之论在《素问·阴阳应象大论》是这样论述的,“帝曰:调此二者奈何?岐伯曰:能知七损八益,则二者可调,不知用此,则早衰之节也。年四十,而阴气自半也,起居衰矣。年五十,体重,耳目不聪明矣。年六十,阴痿,气大衰,九窍不利。
关键词 七损 八益 中医 性医学
下载PDF
五劳七损方对强直性脊柱炎患者Dickkopf-1蛋白水平的影响 被引量:5
9
作者 苏小军 王海东 田雪梅 《中国中医骨伤科杂志》 CAS 2016年第3期26-28,共3页
目的:探索五劳七损方治疗强直性脊柱炎(AS)的有效性、安全性及可能的作用机理。方法:本研究应用ELISA的实验方法检测45例AS患者(AS组)治疗前后及50名健康人(健康组)血清Dickkopf-1(DKK-1)蛋白水平,并检测AS组治疗前后血沉(ESR)、C反应蛋... 目的:探索五劳七损方治疗强直性脊柱炎(AS)的有效性、安全性及可能的作用机理。方法:本研究应用ELISA的实验方法检测45例AS患者(AS组)治疗前后及50名健康人(健康组)血清Dickkopf-1(DKK-1)蛋白水平,并检测AS组治疗前后血沉(ESR)、C反应蛋白(CRP)含量及相关临床疗效评价指标。治疗过程中观察不良反应。结果:治疗前AS组血清DKK-1水平明显低于健康组(P<0.05),经五劳七损方治疗后血清DKK-1水平较治疗前明显升高(P<0.05),且与对照组比较差异无统计学意义(P<0.05)。治疗后ESR和CRP较治疗前均明显降低(P<0.05或P<0.01);相关临床疗效评价指标均较治疗前均明显改善(P<0.05)。患者治疗过程中未见明显不良反应。结论:五劳七损方改善AS患者临床症状、体征疗效显著,其作用机制可能是通过升高血清DKK-1水平实现的。 展开更多
关键词 强直性脊柱炎 五劳七损 Dickkopf-1蛋白
原文传递
五劳七损方治疗肝肾亏虚型腰椎间盘突出症临床疗效观察及安全性分析
10
作者 辛卓萍 《西部微创骨科》 2018年第2期37-39,共3页
目的:观察五劳七损方治疗肝肾亏虚型腰椎间盘突出症的临床疗效。方法:将60例肝肾亏虚型腰椎间盘突出症患者随机分为治疗组和对照组,每组30例,治疗组给予五劳七损方治疗,对照组给予双氯芬酸钠缓释胶囊治疗,分别记录治疗前及治疗15天后患... 目的:观察五劳七损方治疗肝肾亏虚型腰椎间盘突出症的临床疗效。方法:将60例肝肾亏虚型腰椎间盘突出症患者随机分为治疗组和对照组,每组30例,治疗组给予五劳七损方治疗,对照组给予双氯芬酸钠缓释胶囊治疗,分别记录治疗前及治疗15天后患者JOA评分,并进行统计分析。结果:治疗组愈显率为73.33%,对照组为70.00%,2组比较差异无统计学意义(P>0.05)。但治疗组不良反应率为3.33%,对照组为20.00%,2组比较差异有统计学意义(P<0.05)。结论:五劳七损方治疗肝肾亏虚型腰椎间盘突出症与双氯芬酸钠缓释胶囊疗效相当,但五劳七损方对胃肠道的不良反应明显低于双氯芬酸钠缓释胶囊。 展开更多
关键词 腰椎间盘突出症 肝肾亏虚型 五劳七损
原文传递
网友
11
作者 子川 《华人时刊》 1998年第8期38-38,共1页
曾断断续续看过一篇《我们终将被一“网”打尽》长篇连载文章,题目取得很有趣,这个网自然就是“intel”网了。 我不知道人们是否会被一“网”打尽?反正我是入网了。
关键词 邮件表 国际友人 网友 女子 走色 七损 夏目 长篇 浅带 太阳
下载PDF
Effects of β-Aescin on the expression of nuclear factor-κB and tumor necrosis factor-α after traumatic brain injury in rats 被引量:16
12
作者 肖国民 危静 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2005年第1期28-32,共5页
To investigate the inhibiting effect of β-Aescin on nuclear factor-κB (NF-κB) activation and the expression of tumor necrosis factor-α (TNF-α) protein after traumatic brain injury (TBI) in the rat brain, 62 SD ra... To investigate the inhibiting effect of β-Aescin on nuclear factor-κB (NF-κB) activation and the expression of tumor necrosis factor-α (TNF-α) protein after traumatic brain injury (TBI) in the rat brain, 62 SD rats were subjected to lateral cortical impact injury caused by a free-falling object and divided randomly into four groups: (1) sham operated (Group A); (2) injured (Group B); (3) β-Aescin treatment (Group C); (4) pyrrolidine dithocarbamate (PDTC) treatment (Group D). β-Aescin was administered in Group C and PDTC treated in Group D immediately after injury. A series of brain samples were obtained directly 6h, 24 h and 3 d respectively after trauma in four groups. NF-κB activation was examined by Electrophoretic Mobility Shift Assay (EMSA); the levels of TNF-α protein were measured by radio-immunoassay (RIA); the water content of rat brain was measured and pathomorphological observation was carried out. NF-κB activation, the levels of TNF-α protein and the water content of rat brain were significantly increased (P<0.01) following TBI in rats. Compared with Group B, NF-κB activation (P<0.01), the levels of TNF-α protein (P<0.01) and the water content of brain (P<0.05) began to decrease obviously after injury in Groups C and D.β-Aescin could dramatically inhibit NF-κB activation and the expression of TNF-α protein in the rat brain, alleviate rat brain edema, and that could partially be the molecular mechanism by which β-Aescin attenuates traumatic brain edema. 展开更多
关键词 Brain injuries β-Aescin Nuclear factor-KB Tumor necrosis factor-α RATS
下载PDF
Postconditioning of sevoflurane and propofol is associated with mitochondrial permeability transition pore 被引量:48
13
作者 Wei HE Feng-jiang ZHANG +3 位作者 Shao-ping WANG Gang CHEN Cong-cong CHEN Min YAN 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2008年第2期100-108,共9页
Background: Sevoflurane and propofol are effective cardioprotective anaesthetic agents, though the cardioprotection of propofol has not been shown in humans. Their roles and underlying mechanisms in anesthetic postcon... Background: Sevoflurane and propofol are effective cardioprotective anaesthetic agents, though the cardioprotection of propofol has not been shown in humans. Their roles and underlying mechanisms in anesthetic postconditioning are unclear. Mitochondrial permeability transition pore (MPTP) opening is a major cause of ischemia-reperfusion injury. Here we investigated sevoflurane- and propofol-induced postconditioning and their relationship with MPTP. Methods: Isolated perfused rat hearts were exposed to 40 min of ischemia followed by 1 h of reperfusion. During the first 15 min of reperfusion, hearts were treated with either control buffer (CTRL group) or buffer containing 20 μmol/L atractyloside (ATR group), 3% (v/v) sevoflurane (SPC group), 50 μmol/L propofol (PPC group), or the combination of atractyloside with respective anesthetics (SPC+ATR and PPC+ATR groups). Infarct size was determined by dividing the total necrotic area of the left ventricle by the total left ventricular slice area (percent necrotic area). Results: Hearts treated with sevoflurane or propofol showed significantly better recovery of coronary flow, end-diastolic pressures, left ventricular developed pressure and derivatives compared with controls. Sevoflurane resulted in more protective alteration of hemodynamics at most time point of reperfusion than propofol. These improvements were paralleled with the reduction of lactate dehydrogenase release and the decrease of infarct size (SPC vs CTRL: (17.48±2.70)% vs (48.47±6.03)%, P<0.05; PPC vs CTRL: (35.60±2.10)% vs (48.47±6.03)%, P<0.05). SPC group had less infarct size than PPC group (SPC vs PPC: (17.48±2.70)% vs (35.60±2.10)%, P<0.05). Atractyloside coadministration attenuated or completely blocked the cardioprotective effect of postconditioning of sevoflurane and propofol. Conclusion: Postconditioning of sevoflurane and propofol has cardio-protective effect against ischemia-reperfusion injury of heart, which is associated with inhibition of MPTP opening. Compared to propofol, sevoflurane provides superior protection of functional recovery and infarct size. 展开更多
关键词 SEVOFLURANE PROPOFOL POSTCONDITIONING Reperfusion injury Mitochondrial permeability transition pore (MPTP)
下载PDF
中医辨证治疗强直性脊柱炎的临床研究 被引量:24
14
作者 苏小军 王海东 《中华中医药杂志》 CAS CSCD 北大核心 2017年第8期3580-3584,共5页
目的:评价应用补肾温督通络法和补肾清化通络法创制中药处方五劳七损方Ⅰ号和五劳七损方Ⅱ号治疗强直性脊柱炎(AS)的疗效及安全性。方法:采用阳性药、分层区组随机、平行对照及优效性,将163例活动期肾虚督寒瘀阻证和肾虚湿热瘀阻证AS患... 目的:评价应用补肾温督通络法和补肾清化通络法创制中药处方五劳七损方Ⅰ号和五劳七损方Ⅱ号治疗强直性脊柱炎(AS)的疗效及安全性。方法:采用阳性药、分层区组随机、平行对照及优效性,将163例活动期肾虚督寒瘀阻证和肾虚湿热瘀阻证AS患者随机分入中药组和西药组,中药组采取辨证论治,分别予五劳七损方Ⅰ号和五劳七损方Ⅱ号治疗,西药组予柳氮磺吡啶肠溶片口服,疗程24周,采用国际强直性脊柱炎评价(ASAS)工作组制定的ASAS20标准、中医证候疗效评价标准,以及Bath强直性脊柱炎病情活动指数(BASDAI)、Bath强直性脊柱炎功能指数(BASFI)、Bath强直性脊柱炎测量学指数(BASMI)、脊柱痛评分、夜间痛评分、患者总体评价(PGA)、实验室指标C反应蛋白(CRP)及血沉(ESR)综合评价中医辨证治疗AS的临床疗效。结果:五劳七损方Ⅰ号和五劳七损方Ⅱ号治疗AS患者24周后,中医证候疗效总有效率为90.83%,能够显著降低患者的中医证候积分、BASDAI、BASFI、BASMI、脊柱痛评分、夜间痛评分和PGA,与西药组比较差异均有统计学意义(P<0.01,P<0.05)。结论:以补肾温督通络法和补肾清化通络法创制中药五劳七损方Ⅰ号和五劳七损方Ⅱ号治疗AS有一定效果。 展开更多
关键词 强直性脊柱炎 疗效评价 辨证论治 五劳七损方Ⅰ号 五劳七损方Ⅱ号
原文传递
Duplicate preconditioning with sevoflurane in vitro improves neuroprotection in rat brain via activating the extracellular signal-regulated protein kinase 被引量:2
15
作者 王胜 代志刚 +4 位作者 董希玮 郭素香 刘扬 王志萍 曾因明 《Neuroscience Bulletin》 SCIE CAS CSCD 2010年第6期437-444,共8页
Objective Sevoflurane preconditioning has been demonstrated to reduce cerebral ischemia–reperfusion(IR) injury,but the underlying mechanisms have not been fully elucidated.Besides,different protocols would usually ... Objective Sevoflurane preconditioning has been demonstrated to reduce cerebral ischemia–reperfusion(IR) injury,but the underlying mechanisms have not been fully elucidated.Besides,different protocols would usually lead to different results.The objective of this study was to determine whether dual exposure to sevoflurane improves the effect of anesthetic preconditioning against oxygen and glucose deprivation(OGD)injury in vitro.Methods Rat hippocampal slices under normoxic conditions(95%O2/5%CO2)were pre-exposed to sevoflurane 1,2 and 3 minimum alveolar concentration (MAC)for 30 min,once or twice,with 15-min washout after each exposure.The slices were then subjected to 13-min OGD treatment(95%N2/5%CO2,glucose-free),followed by 30-min reoxygenation.The population spikes(PSs)were recorded in the CA1 region of rat hippocampus.The percentage of PS amplitude at the end of 30-min reoxygenation to that before OGD treatment was calculated,since it could indicate the recovery degree of neuronal function.In addition,to assess the role of mitogen-activated protein kinases(MAPKs)in preconditioning,U0126,an inhibitor of extracellular signal–regulated protein kinase(MEK-ERK1/2,ERK1/2 MAPK),and SB203580,an inhibitor of p38 MAPK,were separately added 10 min before sevoflurane exposure.Results Preconditioning once with sevoflurane 1,2,and 3 MAC increased the percentage of PS amplitude at the end of 30-min reoxygenation to that before OGD treatment,from(15.13±3.79)%(control)to(31.88±5.36)%, (44.00±5.01)%,and(49.50±6.25)%,respectively,and twice preconditioning with sevoflurane 1,2,and 3 MAC increased the percentage to(38.53±4.36)%,(50.74±7.05)%and(55.86±6.23)%,respectively.The effect of duplicate preconditioning with sevoflurane 3 MAC was blocked by U0126[(16.23±4.62)%].Conclusion Sevoflurane preconditioning can induce neuroprotection against OGD injury in vitro,and preconditioning twice enhances this effect.Besides,the activation of extracellular signal–regulated protein kinase(MEK-ERK1/2,ERK1/2 MAPK)may be involved in this process. 展开更多
关键词 ELECTROPHYSIOLOGY hippocampal slice oxygen and glucose deprivation neuronal damage sevoflurane preconditioning mitogen-activated protein kinases
原文传递
Decreased PSD95 expression in medial prefrontal cortex(mPFC) was associated with cognitive impairment induced by sevoflurane anesthesia 被引量:2
16
作者 Yun-zhi LING Wei MA +2 位作者 Li YU Ye ZHANG Qi-sheng LIANG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2015年第9期763-771,共9页
Objective: Though sevoflurane has been widely used as an anesthetic in surgery, recent studies have shown that exposure to sevoflurane alone could lead to postoperative cognitive dysfunction (POCD), of which the me... Objective: Though sevoflurane has been widely used as an anesthetic in surgery, recent studies have shown that exposure to sevoflurane alone could lead to postoperative cognitive dysfunction (POCD), of which the mechanisms still remain largely unknown. The medial prefrontal cortex (mPFC) is known to be implicated in various cognitive impairments, including working memory and attentional processes. In the present study, we tried to identify dysregulated gene expression in mPFC and investigate the underlying mechanisms involved in POCD. Methods: Behavioral tests, including elevated plus-maze, O-maze, and Y-maze tests, were performed on Wistar rats exposed to sevoflurane. Whole-genome mRNA profiling of mPFC from Wistar rats after exposure to sevoflurane was carried out. Real-time polymerase chain reaction (PCR) was done to verify the differentially expressed genes. Results: Significant impairment of working memory of rats after exposure to sevoflurane was observed. A total of 119 of 7319 detected mRNAs showed significantly different expression between rats with and without sevoflurane exposure (fold change (FC)〉2.0, P〈0.05, and false discovery rate (FDR)〈0.05), among which 74 mRNAs were down-regulated and 45 mRNAs were up-regulated. Postsynaptic density-95 (PSD95, also named DLG4) showed the most significantly de- creased expression in mPFC and further investigation indicated that PSD95 expression level was correlated with spatial working memory performance. Conclusions: Our study revealed that PSD95 might be involved in the mecha- nism of POCD, which could provide clues for preventing POCD in clinical operations. 展开更多
关键词 SEVOFLURANE Cognitive dysfunction PSD95
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部